HEALTHX Health X Platform (HEALTHX) Q1 FY27 results (Apr–Jun 2026) and concall
Health X Platform Limited delivered a strong Q1 FY27, marked by robust revenue growth across its core platforms and a return to positive PAT. Strategic investments in technology and geographical expansion are driving momentum, though management prioritizes long-term growth and cash flow over near-term EBITDA profitability. The company is expanding its infrastructure and expects continued strong growth, particularly from its high-margin JITO private label.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue down 20.0%, net profit down 363.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 −9% | 0 −18% | 0 −10% | 0 −20% |
| EBITDA | -0 | -0 | -0 | -0 | -0 +44% | -0 −48% | -0 +4% | -0 −72% |
| Net profit | -0 | -0 | -0 | -0 | -0 +12% | -0 −310% | -0 −114% | -1 −364% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
